In today's deal-driven and reporting-intensive environment, valuation is central to investor confidence, transaction strategy, and regulatory compliance. At FinApt, we approach valuation as both a technical exercise and a strategic tool. Whether for acquisition, restructuring, financial reporting, litigation, or investor discussions, we deliver defensible, insight-driven valuations aligned with purpose and context.
Why You Need It
Valuation impacts deal pricing, tax outcomes, financial statements, and investor decisions. It supports:
- M&A (buy-side/sell-side) decisions
- Capital raising and investor negotiations
- Financial reporting (IFRS compliance, impairment testing, PPA)
- Shareholder exits, disputes, and internal reorganizations
- Regulatory or court-driven assessments
Stakeholders increasingly demand transparency, independent analysis, and logical valuation frameworks to trust numbers and act decisively.
What Typically Goes Wrong
- Over-reliance on headline multiples without adjusting for risk, growth, or synergies
- Models disconnected from actual cash generation or business drivers
- Circular logic in DCFs, or flawed assumptions leading to ungrounded values
- Inadequate consideration of control premiums, minority discounts, or liquidity constraints
- Lack of documentation to support fair value positions during audit or litigation
Valuation Services
We tailor our valuation work to the specific objective, audience, and nature of the business. Our deliverables include:
Business / Equity Valuation
Determining enterprise and equity value using DCF, market multiples, NAV, and other appropriate methods tailored to the business model and risk profile.
Pre-Deal Valuation & Synergy Modelling
Supporting investors and acquirers in assessing standalone value, quantifying synergies, and evaluating deal economics.
Purchase Price Allocation (PPA)
Allocating consideration to tangible and intangible assets in line with IFRS 3, including opening balance sheet advisory and audit support.
Fairness Opinions
Independent financial evaluation of transaction terms to assist boards and stakeholders in meeting fiduciary duties and reducing deal risk.
Periodic Investment Valuation
Performing quarterly/semi-annual valuations of unlisted investments for PE/VC, family offices, and institutional portfolios.
Impairment Testing
Assessing recoverable amounts for goodwill and intangible assets under IAS 36, including support with modelling and audit defense.
Financial Modelling
We build, review, and stress-test financial models to support capital allocation, valuation, and investment decisions.
Our financial modelling services include:
Financial Model Build
Custom-built DCF, LBO, operational, or scenario-based models structured to support strategic decisions or transactions.
Financial Model Review
Validation of assumptions, formulas, linkages, and structure to ensure model logic is sound and investor-ready.
Financial Model Support
Ongoing maintenance and refinement of models for reporting, board presentations, or capital markets communication.
Frequently Asked Questions
A formal valuation is typically required for M&A transactions (buy-side or sell-side), shareholder exits or disputes, capital raising, regulatory or court-driven assessments, financial reporting under IFRS (such as purchase price allocation or impairment testing), and internal restructuring. Stakeholders — including investors, auditors, and regulators — increasingly expect independent, defensible valuations as part of their decision-making process.
We apply a range of methodologies depending on the purpose, business profile, and data availability. These include discounted cash flow (DCF), comparable company and precedent transaction multiples, net asset value (NAV), dividend discount models, and relief-from-royalty or multi-period excess earnings methods for intangible assets. We always triangulate across methods and document why each was selected or excluded.
Under IFRS 3 (Business Combinations), an acquirer must allocate the purchase consideration to identifiable assets and liabilities at fair value, with any residual recognized as goodwill. PPA involves valuing tangible assets, intangible assets (such as customer relationships, brands, and technology), and contingent items. It directly impacts the acquirer's balance sheet, future amortization charges, and impairment testing.
IAS 36 requires entities to test goodwill and certain intangible assets for impairment at least annually — or whenever there is an indication of impairment. This involves comparing the carrying amount of an asset (or cash-generating unit) to its recoverable amount, which is the higher of value-in-use and fair value less costs of disposal.
A fairness opinion is an independent financial assessment of whether the terms of a proposed transaction are fair from a financial perspective. It is typically sought by boards of directors, special committees, or shareholders to fulfil fiduciary duties and reduce litigation risk. Fairness opinions are common in related-party transactions, management buyouts, squeeze-outs, and deals where conflicts of interest may arise.
Timelines depend on scope, complexity, and data availability. A focused single-entity business valuation typically takes two to four weeks. Multi-entity valuations, PPA engagements, or impairment testing mandates involving complex modelling may take four to eight weeks. For deal-related work, we align timelines to transaction deadlines and can mobilise quickly when required.
Yes. We build, review, and stress-test financial models across DCF, LBO, operational, and scenario-based frameworks. Whether you need a model built from scratch for a transaction, a third-party review to validate assumptions and structure, or ongoing refinement for board reporting and capital markets communication, we deliver models that are robust, transparent, and investor-ready.
Let's Help You Defend Value with Confidence
We deliver defensible, purpose-built valuations and models that stand up to investor scrutiny, audit requirements, and board-level decisions. Whether you're pricing a deal, planning for impairment, or defending value in negotiations, we provide valuation clarity where it matters most.
Speak to Our Financial and Transaction Advisory Team